In new research, Cailtin K. Myers and Ezekiel Hooper find that birth rates in the United States have declined as a result of the introduction of the iPhone. They theorize that the smartphone is crowding out the market for attention, offering a device to fill users’ time that replaces forming in-person relationships that typically create children. 

COMMENTARY

If Venture Capital Believes Merger Control Stymies Growth, They Have the Resources To Prove It

Supporters of more robust antitrust policy have pointed to the subsequent success of Figma after authorities blocked Adobe’s acquisition of it. Skeptics, including venture capitalists, have argued that the one case reveals nothing systematic about the benefits of stronger merger review. Venture capitalists happen to be the one party with the data and resources to fund the studies to show any systematic correlation one way or the other. They should do so, writes Shishene Jing.

RESEARCH

When Competitors Share Owners, They Automate More and Hire Less

In a new paper, Joseph Emmens, Dennis C. Hutschenreiter, Stefano Manfredonia, Felix Noth, and Tommaso Santini find that when competitors for the same pool of workers share investors, they increase their innovation to automate tasks and slow down hiring.    
spot_img
spot_img

A New Capitalisn’t Episode

Subscribe to promarket newsletter

Join our email newsletter

LATEST

How OxyContin and the Opioid Epidemic Reshaped American Communities

The OxyContin epidemic had large demographic effects on communities in the United States. In new research, Carolina Arteaga, Victoria Barone, and Stephen Claassen find that Purdue Pharma’s marketing strategy targeted specific areas, causing college-educated residents to flee and increasing fertility rates among the most affected populations.

The Draft Merger Guidelines Must Make More Explicit the EU’s Constitutional Values

The EU’s constitutional framework and European Union Court of Justice’ case law have evolved since the European Union enacted the first Merger Guidelines in 2004. The revised Merger Guidelines should better engage with these developments and reflect the priority constitutional values and democracy now play in economic policy, writes Kati Cseres.

What Economists Are Missing About AI

In a new working paper, Benjamin Verschuere and Angus Cameron argue that the wide dispersion in economists' forecasts for the impact of artificial intelligence on the economy stems from two gaps. The first is that estimates for growth, jobs, and prices are each built in isolation, with no single framework to reconcile them. The second is that models fixate on AI’s current capabilities, rather than on how fast it spreads and how much of a given job it can eventually reach. The authors build a unified framework that predicts roughly $2 trillion in long-run output gains, the loss of about 20 million American jobs, and falling prices.

Presidential Control of Independent Agencies Has a Price

The Supreme Court's decision in Trump v. Slaughter strips independent agencies of removal protections that made regulatory policy predictable across administrations. In new research, Brian Feinstein and Daniel Hemel find that equity markets assign real value to precisely that kind of insulation.

Bank Mergers Aren’t Raising Your Mortgage Rate

In new research examining 44 million U.S. mortgages and nearly 5,000 bank mergers over three decades, Celso Brunetti, Jeffrey H. Harris, and Ioannis Spyridopoulos find that bank consolidation does not raise mortgage rates, restrict credit access, or degrade loan quality. Local mortgage markets remain intensely competitive. 

READING LISTS

Americans spend significantly more on health care than any other country. Why? Answers to this question range from hospital monopolies to perverse incentives to opaque pricing to medical licensing to pharmaceutical firms abusing IP practices to “creeping consolidation.” Why is the US health care system so broken? And what can antirust do about it? Catch-up on our coverage of antitrust and the US health care system.

Antitrust as a Cure for the Private Equity Disease

The United States healthcare system has experienced an expansion of private equity ownership. In new research, Theodosia Stavroulaki argues that private equity acquisitions risk harming healthcare by increasing prices, reducing quality of care, limiting access to care, and hurting the labor force.

Pharma’s AI Boom Has Bet on the Wrong Bottleneck

Investors have poured billions into using artificial intelligence to discover new drugs, and 2026 is the first real test of whether AI-designed medicines actually helps patients. The boom has genuinely transformed the search for molecules — but that was never the costly, failure-prone part of making a medicine, and there AI has so far had little to add. Capital, and the public subsidies have not yet priced the difference, writes Michael A. Santoro.

The Pharmaceutical Benefits Manager Settlements Are a Novel Advance for the FTC and Competition Enforcement

In February, the Federal Trade Commission settled with pharmaceutical benefits manager (PBM) Express Scripts. The FTC had sued Express Scripts and two other large PBMs under the long dormant Section 5 of the FTC Act, which targets “unfair methods of competition.” The settlement suggests that the FTC may succeed in addressing the convoluted contracts between PBMs, drug manufacturers, health insurers, and employers that drive up drug prices for Americans. It also opens unchartered territory for antitrust enforcement and the limits of Section 5, argue Fiona Scott Morton and Mariah Smith.

How Competition Has Increased Fraud in Medicare’s DME Program

In new research, Renuka Diwan, Paul Eliason, Riley League, Ryan C. McDevitt, James W. Roberts, and Jetson Leder-Luis investigate how Medicare’s shift to a competitive bidding system to reduce prices has inadvertently shifted market share to fraudulent suppliers.

George J. Stigler, one of the most influential economists of the 20th century, won the Nobel Prize in Economic Sciences in 1982 “for his seminal studies of industrial structures, functioning of markets, and causes and effects of public regulation.” His research upended the idea that government regulation was effective at correcting private-market failures. Stigler introduced the idea of regulatory capture, in which regulators could be dominated by special interests. These regulators would work for the benefit of large, monied organizations rather than the public good. Catch up on ProMarket's coverage of his legacy.

Dynamic Competition Is (Also) a Pro-Enforcement Framework

The European Union’s draft Merger Guidelines give a central role to dynamic competition in merger review. Some scholars have criticized dynamic competition as an analytical tool that seems to always discourage government intervention, given how quickly and unexpectedly—or dynamically—innovation can remake a market. Nicolas Petit, Selcukhan Unekbas, Bowman Heiden, and Pierre Regibeau argue this critique ignores the several large cases in which regulators used dynamic competition to intervene in a merger.

The Proposed California Billionaire Wealth Tax Produces Inequities and Adverse Incentives

California’s proposed wealth tax on billionaires will struggle to accurately value and tax the wealth of California’s richest. Rather than fund the state’s massive budgetary commitments, the bill may drive away its largest taxpayers, write Ray Ball and Andrew Sutherland.

Even Fervent Musk Fans Should Worry About the SpaceX Governance Risks

Public investors poured funds into buying SpaceX shares upon its mid-June IPO, and they can be expected to continue to do so heavily over...

South Africa Shows How the EU Merger Guidelines Can Account for Non-Economic Factors

The draft EU Merger Guidelines open merger analysis to non-economic considerations, including choice, supply chain resilience, and sustainability. However, they do not yet explain how these considerations will be paired with a traditional consumer welfare analysis of price and quantity. Maciej Bernatt and Simbarashe Tavuyanago look to South Africa to devise a “vulnerable consumer test” that can help bridge these economic and non-economic goals.

Satya Nadella’s AI Warning Is a Sales Pitch

Microsoft CEO Satya Nadella’s argument that businesses need to be able to easily switch between artificial intelligence models is correct but elides the fact, if implemented, his advice would direct investment toward Azure, Microsoft's cloud business, which benefits regardless of which model wins. To avoid similar market abuse by cloud providers, portability at that level must exist, too, writes Javaid Sofi. On June 14, Microsoft CEO Satya Nadella posted a long argument on X about how companies should think about maximizing value from artificial...

When is Corporate Bribery a Good Investment?

In new research, Vishavdeep Sharma and Krishnendu Ghosh Dastidar analyze corporate corruption through the lens of market competition. Firms often bribe officials to block rivals from entering their markets, and their incentive to do so depends less on how competitive a market is than on what kind of competition it has.

The EU’s Merger Guidelines Risk Undermining Their Own Progress

The European Union’s draft Merger Guidelines strengthen competition enforcement by acknowledging the potential harms of market concentration to society, including worker bargaining power and more vulnerable democratic institutions. However, Max von Thun and Claire Lavin argue that this progress is undermined by the introduction of a bias for scale and efficiency loopholes, which give large corporations more paths to complete a merger.

COLUMNS

spot_imgspot_img